EC Healthcare stock analysis
Want to see HK:2138 full AI Analyst Report?
EC Healthcare (2138) Stock Price & Analysis
2138 Stock Chart & Stats
- Day’s Range
- HKD 0.55 - HKD 0.60
- 52-Week Range
- HKD 0.34 - HKD 0.72
- Previous Close
- HKD 0.55
- Volume
- N/A
- Average Volume (3M)
- 163.13K
- Market Cap
- HKD 651.87M
- Enterprise Value
- HKD 1.14B
- Total Cash (Recent Filing)
- HKD 988.66M
- Total Debt (Recent Filing)
- HKD 1.26B
- Price to Earnings (P/E)
- ―
- Beta
- 0.81
- Next Earnings
- Nov 26, 2026 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Dec 30, 2024
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Positive Cash Generation
Positive operating and free cash flow provide internal funding capacity even while reported earnings are negative. This can support ongoing operations and selected investment without relying entirely on external capital, although the declining cash-flow trend means the strength requires continued monitoring.
Consumer Healthcare Network
A consumer-facing network focused on preventive care, health check-ups, and outpatient services gives EC Healthcare an established platform for reaching patients across multiple healthcare needs. This operating model can support continued service delivery and brand presence over the medium term.
Positive EBITDA Margin
A mid-teens EBITDA margin indicates that the operating platform still produces meaningful earnings before depreciation, amortization, interest, and other below-operating pressures. This provides a potential base for recovery if revenue stabilizes and the company improves conversion into operating and net profit.
Bears Say
Revenue Contraction And Losses
Sustained revenue contraction is weakening the scale of the business, while the shift from profit in 2023 to losses through 2026 shows materially reduced earnings power. Continued top-line pressure can limit operating leverage, constrain reinvestment, and make a return to durable profitability more difficult.
Gross Margin Volatility
The sharp change in gross margin makes profitability difficult to forecast and raises concerns about earnings quality and comparability across periods. Whether driven by mix, pricing, accounting, or cost reclassification, such volatility reduces confidence in the durability of reported margins and future earnings.
Rising Leverage And Shrinking Equity
Rising debt relative to a shrinking equity base increases financial risk while the company is already loss-making. The weaker capital cushion may reduce flexibility to absorb further deterioration or fund growth internally, and continued losses could push leverage higher if profitability does not stabilize.
EC Healthcare News
2138 FAQ
What was EC Healthcare’s price range in the past 12 months?
What is EC Healthcare’s market cap?
When is EC Healthcare’s upcoming earnings report date?
How were EC Healthcare’s earnings last quarter?
Is EC Healthcare overvalued?
Does EC Healthcare pay dividends?
What is EC Healthcare’s EPS estimate?
How many shares outstanding does EC Healthcare have?
What happened to EC Healthcare’s price movement after its last earnings report?
Which hedge fund is a major shareholder of EC Healthcare?
What is the TipRanks Smart Score and how is it calculated?
EC Healthcare Stock Smart Score
Company Description
EC Healthcare
EC Healthcare, an investment holding firm, delivers an extensive range of medical and healthcare services throughout Hong Kong, Macau, and mainland China. Its operations are structured into three primary divisions: Medical, Aesthetic Medical and Beauty and Wellness, and an 'Others' category. The company's diverse service offerings include quasi-medical treatments, beauty and wellness programs, medical imaging, surgical procedures, aesthetic medicine, dentistry, hair restoration, vaccinations, chiropractic care, psychological support, and orthopedic services. Beyond direct patient care, EC Healthcare also provides administrative and management support, laboratory diagnostics, various marketing and performance marketing solutions, and even travel agency services. Furthermore, it retails beauty and skincare products, manages healthcare machinery, engages in property investment, offers multi-channel networking, and extends its expertise to veterinary services. Its product and service portfolio is primarily marketed under proprietary brands such as PRODERMA LAB, Swissline, Suissebeaute, and re:HEALTH. Established in 2005 and headquartered in Mong Kok, Hong Kong, the company was formerly known as Union Medical Healthcare Limited before rebranding to EC Healthcare in April 2021.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Lyn Wade Lu
- Employees
- 2,400
- Website
- www.echealthcare.com
- Address
- HK
EC Healthcare (2138) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 5 | 2 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 12 | 0 | 0 |








